During the past decade, Mid-Florida Hematology & Oncology Centers, PA conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mid-Florida Hematology & Oncology Centers, PA" #1 sponsor was "Novartis Pharmaceuticals" with 2 trials, followed by "Apellis Pharmaceuticals, Inc." with 1 trials sponsored, "Beijing InnoCare Pharma Tech Co., Ltd." with 1 trials sponsored, "G1 Therapeutics, Inc." with 1 trials sponsored and "Genentech, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mid-Florida Hematology & Oncology Centers, PA" #1 collaborator was "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Mid-Florida Hematology & Oncology Centers, PA" are "Advanced Solid Tumors" (1 trials), "Breast Cancer" (1 trials), "Chemotherapeutic Toxicity" (1 trials), "Cholangiocarcinoma" (1 trials) and "Colorectal Cancer Metastatic" (1 trials). Many other conditions were trialed in "Mid-Florida Hematology & Oncology Centers, PA" in a lesser frequency.

Most popular intervention types in "Mid-Florida Hematology & Oncology Centers, PA" are "Drug" (9 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Carboplatin" (1 trials), "Drug ICP-192" (1 trials), "Fostamatinib 150 mg bid" (1 trials) and "Pegcetacoplan" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mid-Florida Hematology & Oncology Centers, PA" are 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Mid-Florida Hematology & Oncology Centers, PA". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Mid-Florida Hematology & Oncology Centers, PA, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Mid-Florida Hematology & Oncology Centers, PA, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".